What is the recommended intravenous dosing protocol for furosemide (Lasix) in acute volume overload?

Intravenous Furosemide Dosing for Acute Volume Overload

For patients with acute heart failure and volume overload, start with IV furosemide 40-160 mg as a single bolus (or 1-2.5 times the home oral dose if already on diuretics), administered slowly over 1-2 minutes, with reassessment at 2 and 6 hours to guide dose escalation. 1, 2

Initial Dosing Strategy

For Diuretic-Naïve Patients

• Start with 20-40 mg IV bolus 3, 4, 2
• Administer slowly over 1-2 minutes 2
• This lower range minimizes risk of excessive diuresis and electrolyte disturbances

For Patients Already on Loop Diuretics

• Convert oral dose to IV at 1-2.5 times the home dose 1
• The 2019 ACC Expert Consensus provides the most current guidance: usual inpatient dosing is 40-160 mg IV once to three times daily, with a maximum of 200 mg per dose 1
• Never start below the equivalent of their home dose - this is a common pitfall that leads to inadequate decongestion 5

Monitoring and Dose Titration

Critical Time Points for Assessment

At 2 hours post-dose:

• Check spot urinary sodium - target ≥50-70 mmol/L 6
• If below target, double the dose 6

At 6 hours post-dose:

• Assess urine output - target ≥100-150 mL/hour (600-900 mL total) 6
• If inadequate, increase dose by 20 mg increments 2

Dose Escalation Protocol

• Double the dose every 2 hours until adequate diuresis achieved 3, 2
• Maximum recommended: 200 mg per bolus dose 1
• Daily maximum: 240 mg in first 24 hours per ESC guidelines 3, though ACC allows up to 600 mg/day in refractory cases 1
• Do not exceed 4 mg/min infusion rate if using continuous infusion 2

Bolus vs. Continuous Infusion

Intermittent boluses are equally effective as continuous infusion and should be the default approach 1, 7. The landmark DOSE trial found no significant difference in outcomes between these strategies 6.

However, continuous infusion (5-20 mg/hour, maximum 40 mg/hour) may be considered when 1:

• Bolus dosing proves inadequate
• Patient requires ICU-level monitoring anyway
• Very high total daily doses are needed

Important caveat: Continuous infusion requires pH adjustment above 5.5 and cannot be mixed with acidic solutions 2. Many hospitals restrict this to ICU settings, making bolus dosing more practical 8.

Diuretic Resistance Management

When initial dosing fails (approximately 30-40% of patients), escalate systematically 8:

1. First-line: Increase furosemide dose (double previous dose) 3, 5

2. Second-line: Add thiazide-type diuretic for sequential nephron blockade 1, 3, 4

   • Hydrochlorothiazide 25-50 mg PO 1
   • Metolazone 2.5-5 mg PO 1
   • Chlorothiazide 0.5-1 g IV 1

3. Consider acetazolamide 500 mg IV once daily - emerging evidence from the ADVOR trial supports early combination therapy, particularly when baseline bicarbonate ≥27 mmol/L 6

Critical Safety Monitoring

Daily Requirements

• Electrolytes (especially potassium, sodium, magnesium) - check at least daily 1
• Renal function (creatinine, BUN) - expect mild transient increases during effective decongestion 1
• Daily weights at same time 5
• Strict intake/output monitoring 5

Contraindications and Cautions

Do not use IV furosemide when: 3, 4

• SBP <90 mmHg (unless correcting hypovolemia first)
• Severe hyponatremia
• Acidosis
• Anuria from acute renal failure

Reduce dose or hold temporarily if:

• Creatinine increases >30% from baseline 8
• Severe hypokalemia develops (can temporarily hold furosemide) 9
• Signs of hypovolemia appear 3, 4

Special Populations

Elderly Patients

• Start at lower end of dosing range 2
• More susceptible to volume depletion and electrolyte abnormalities 8

Renal Impairment

• Higher doses often required (up to 1000 mg/day in severe cases) 6
• GFR <30 mL/min: expect reduced response, may need combination therapy earlier 8

Hepatic Cirrhosis

• Initiate therapy only in hospital setting 2
• Risk of precipitating hepatic coma with rapid diuresis 2
• Strict observation mandatory during diuresis period 2

Common Pitfalls to Avoid

1. Starting with inadequate doses in patients already on chronic diuretics - always match or exceed home dose equivalents
2. Delaying dose escalation - reassess at 2 and 6 hours, not the next day
3. Mixing furosemide with acidic IV solutions - causes precipitation 2
4. Administering too rapidly - increases ototoxicity risk, especially with doses >40 mg 2
5. Discharging patients with residual congestion - associated with poor outcomes and early readmission 6

The 2019 ACC guidelines 1 represent the most current and comprehensive approach, superseding older recommendations while incorporating evidence from trials like DOSE. The key is aggressive early dosing with frequent reassessment rather than conservative "wait and see" approaches that prolong congestion.